Basilea Pharmaceutica Ltd
Dr. Günter Ditzinger, German citizen, has served as Chief Technology Officer since February 2016. He joined Basilea in 2002 as CMC Project Leader & Pharmaceutical Development Manager. He was promoted in 2009 to Head of Pharmaceutics in which position he led the pharmaceutical development and manufacturing group and acted as deputy Chief Technology Officer. Prior to joining Basilea, he held various positions with increasing responsibility at Hoechst Marion Roussel in Frankfurt, Germany and at Novartis Pharma AG in Basel, Switzerland. Dr. Ditzinger holds a PhD in Pharmaceutical Technology from the Johann Wolfgang Goethe University in Frankfurt/Main, Germany.